Drug pricing
The government intends to reform the way in which drugs purchased by the NHS are priced. It aims to ensure that drug costs more fully reflect clinical benefit and to improve patient access to new treatments. This POSTnote outlines current pricing policy and examines other options to evaluate drug pricing, including “value-based” pricing.
Short title:
Drug pricing
Start date:
2010-07
End date:
2010-10
Homepage:
http://www.parliament.uk/documents/post/postpn_364_Drug_Pricing.pdf
Focus:
Health
Project leader:
Parliamentary Office of Science and Technology of the UK Parliament (POST)
Country:
UK

 Back